Hyderabad-based genomics and microbiome testing firm MapMyGenome has acquired Canadian company Microbiome Insights, a globally recognised leader in microbial sequencing, in a move aimed at expanding its global presence and deepening scientific capabilities.

The acquisition includes Microbiome Insights’ CAP-accredited laboratory in Canada, along with its intellectual property portfolio. This development will strengthen MapMyGenome’s research and clinical offerings, particularly in the fields of metagenomics, transcriptomics, and targeted metabolomics. It also marks the company’s formal entry into the North American market with plans to roll out integrated genomics and microbiome testing services across the region, said a release.

MapMyGenome CEO and founder Anu Acharya described the acquisition as a major milestone in the company’s global strategy. “The human microbiome is pivotal to health, and this acquisition positions us as a leader in this area. It accelerates our North American footprint, aligning with our strategic vision of growth through targeted acquisitions leading up to our listing on the Indian market later this year,” she said.

Malcolm Kendall, CEO of Microbiome Insights, called the merger an opportunity to enhance service quality and broaden global reach. “Joining forces with MapMyGenome provides the resources and capabilities to offer higher quality services to our clients and accelerate growth. The combination of their expertise in AI-driven genomics solutions and our deep microbiome expertise will result in a new standard of cutting-edge services for clients worldwide,” he said.